These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6423858)

  • 21. Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues.
    Laufer MR; Rein MS
    Clin Obstet Gynecol; 1993 Sep; 36(3):668-78. PubMed ID: 8403613
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epsilon-aminocaproic acid (EACA) in treatment of excessive menstrual bleeding in girls with chronic thrombocytopenia].
    Rokicka-Milewska R
    Pediatr Pol; 1970 Mar; 45(3):323-7. PubMed ID: 5441592
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of a gonadotropin-releasing hormone analogue on the glucose metabolism in a diabetic patient.
    Coddington CC; Hassiakos DK; Harrison HC; Brzyski RG; Jones GS
    Gynecol Obstet Invest; 1990; 30(4):246-8. PubMed ID: 2127036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadorelin--synthetic LH-RH.
    Med Lett Drugs Ther; 1983 Nov; 25(649):106-7. PubMed ID: 6358816
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of amenorrhea with a LH-RH-analogue as nasal spray].
    Friedrich F; Kemeter P
    Wien Med Wochenschr; 1982 Jan; 132(1):19-21. PubMed ID: 6803443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of undescended testicles with gonadorelin (LH-RH) via nose spray; initial experiences and results].
    de Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Visser HK; Molenaar JC
    Ned Tijdschr Geneeskd; 1984 Nov; 128(44):2081-4. PubMed ID: 6150444
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
    Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
    Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
    Nesković-Konstantinović Z; Radulović S; Vuletić L
    Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of menorrhagia in female stem cell transplant recipients.
    Sica S; Sorà F; Laurenti L; Chiusolo P; Piccirillo N; Scirpa P; Leone G
    Bone Marrow Transplant; 2005 Apr; 35(8):827. PubMed ID: 15750605
    [No Abstract]   [Full Text] [Related]  

  • 31. The primary level of gonadotropins and the LH-RH test in hypothalamic syndromes in women.
    Baron J; Bućko J; Chwalisz K
    Mater Med Pol; 1980; 12(1-2):110-3. PubMed ID: 6799702
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation].
    Sun Q; Huang HY; Zhou YD; Mao F; Yang YQ; Xing Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):60-2. PubMed ID: 12905610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].
    Wikiera B; Wasikowa R
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):13-8. PubMed ID: 16704856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [LH-releasing hormone in the functional diagnosis of the menstruation disorders].
    Wyss HI; Richter R; Schneider HP; Schindler AE; Staemmler HJ
    Gynakol Rundsch; 1973; 13():Suppl 1:44-5. PubMed ID: 4593971
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum FSH and LH levels in men after administration of a long-acting LH-RH preparation.
    Laczi F; Julesz J; Bártfai G; Sas M; László FA
    Acta Med Acad Sci Hung; 1982; 39(3-4):125-31. PubMed ID: 6821016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical use of LHRH analogs].
    Baranowska B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1005-7. PubMed ID: 6390370
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog.
    Yokoyama M; Arisawa C; Ando M
    Int J Urol; 2006 Apr; 13(4):457-9. PubMed ID: 16734874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse effects of a potent LH-RH antagonist on the LH and FSH release.
    Kovács M; Koppán M; Mezó I; Teplán I
    Acta Biol Hung; 1994; 45(2-4):285-96. PubMed ID: 7725823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leuprolide and other LH-RH analogues.
    Adjei AL; Hsu L
    Pharm Biotechnol; 1993; 5():159-99. PubMed ID: 8019693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.